![]() ![]() 238000005352 clarification Methods 0.000 claims description 14.238000005277 cation exchange chromatography Methods 0.000 claims description 14.238000005119 centrifugation Methods 0.000 claims description 15.238000000576 coating method Methods 0.000 claims description 16.239000011248 coating agent Substances 0.000 claims description 16.239000003957 anion exchange resin Substances 0.000 claims description 18.238000011100 viral filtration Methods 0.000 claims description 19.239000012501 chromatography media Substances 0.000 claims description 44.238000005571 anion exchange chromatography Methods 0.000 claims description 51.OC()=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 67 UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances.102000005614 monoclonal antibodies Human genes 0.000 claims description 85.108010045030 monoclonal antibodies Proteins 0.000 claims description 85.238000005341 cation exchange Methods 0.000 claims description 111.238000004587 chromatography analysis Methods 0.000 claims description 194.OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 988.239000003575 carbonaceous material Substances 0.000 claims abstract description 104.238000000034 method Methods 0.000 claims abstract description 222.108090000623 proteins and genes Proteins 0.000 claims abstract description 644.102000004169 proteins and genes Human genes 0.000 claims abstract description 644.230000001603 reducing Effects 0.000 title claims description 58.238000001742 protein purification Methods 0.000 title claims abstract description 30.239000012535 impurity Substances 0.000 title claims abstract description 255.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US201161575349P external-priority Application filed by Emd Millipore Corporation filed Critical Emd Millipore Corporation Publication of WO2013028330A2 publication Critical patent/WO2013028330A2/en Publication of WO2013028330A3 publication Critical patent/WO2013028330A3/en Links ( en Inventor Nanying Bian Christopher Gillespie Matthew Stone Mikhail Kozlov Jie Chen Martin Siwak Original Assignee Emd Millipore Corporation Priority date (The priority date is an assumption and is not a legal conclusion. Google Patents WO2013028330A2 - Methods of reducing level of one of more impurities in a sample during protein purification WO2013028330A2 - Methods of reducing level of one of more impurities in a sample during protein purification ![]()
0 Comments
Leave a Reply. |